MedPath

Cognitive Impairment in Patients With Heart Failure

Completed
Conditions
Cognitive Impairment
Heart Failure
Interventions
Drug: diuretics, inotropica
Registration Number
NCT00837889
Lead Sponsor
Universität des Saarlandes
Brief Summary

The aim of the present study is threefold: investigating 1) specific cognitive impairments in patients with congestive heart failure, 2) whether cognitive impairments in patients with decompensated heart failure improve after medical recompensation and 3) whether cognitive functioning is related to the long-term prognosis (mortality, rehospitalisation) of those patients.

Detailed Description

The daily routine in clinical settings often shows cognitive impairments in patients with congestive heart failure. Recent studies reported declines in cognitive functioning such as executive functions, episodic memory, perceptual speed and attention. However, less is known regarding the differential impairments of cognitive functioning in patients with decompensated heart failure.

Study objectives:

1. Identifying specific cognitive impairments in patients with congestive heart failure compared to healthy controls

2. Evaluating the influence of acute decompensation in congestive heart failure on cognitive functioning

3. Investigating the effects of medical treatment on cognitive functioning in patients with decompensated heart failure

4. Exploring long-term effects of cognitive and physiological status on hospitalisation and/or mortality

Study design:

Cognitive functions of patients with decompensated heart (NYHA III-IV) failure are compared to age and gender matched patients with congestive heart failure (NYHA III-IV) without symptoms of cardiac decompensation and with healthy controls. Decompensated patients are tested before and after medical recompensation. For matched patients and controls, the pretest-posttest timing is based on the recompensation time of the respective patient with decompensated heart failure.

The neuropsychological test battery includes measures of episodic memory, working memory, short-term memory, executive functions, perceptual speed and intelligence. In addition, the study applied standardized questionnaires of self assessed quality of life and depression. Relevant physiological data, such as left ventricular systolic function and N-terminal pro brain natriuretic peptide (NT-pro-BNP), are recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • decompensated heart failure patients
  • NYHA III-IV
  • ejection fraction < 35%
Exclusion Criteria
  • psychosis
  • dementia
  • major depression
  • reanimation (<3month)
  • patients with assist device system

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
decompensated heart failure patientsdiuretics, inotropica-
Primary Outcome Measures
NameTimeMethod
cognitive function in decompensated heart failure patients measured by a cognitive test batterywithin 48h of hospitalisation
cognitive function before and after medical recompensation measured by a cognitive test batteryindividual time to recompensate
differences in cognitive performance between decompensated heart failure patients, patients with chronic heart failure and healthy controls14 months (+/-2 month)
Secondary Outcome Measures
NameTimeMethod
long-term development of cognitive functioning in patients with heart failure after acute decompensation3, 6, 12 and 18 months after acute decompensation
all cause mortality12 month

Trial Locations

Locations (2)

Department of Cardiology, University of the Saarland

🇩🇪

Homburg, Saarland, Germany

Developmental Psychology Unit, Saarland University

🇩🇪

Saarbruecken, Saarland, Germany

Department of Cardiology, University of the Saarland
🇩🇪Homburg, Saarland, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.